Amgen's autoimmune drug succeeds in late-stage trial

Amgen said on Tuesday its experimental drug to treat an autoimmune ​disease that attacks the body's moisture-producing ‌glands met the main goal of reducing disease activity in a late-stage trial.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。